Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

9449

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the femoropopliteal segment, in anatomies such as below the knee and the iliac arteries.

As the clinical experience and evidence base for this technology grows, Holden, one of the earliest users in the world of IVL, shares his views on the broadening applications for IVL in larger vessel beds, such as the common femoral artery and facilitating transfemoral access for large bore devices.

This video is sponsored by Shockwave Medical.


LEAVE A REPLY

Please enter your comment!
Please enter your name here